Higher-risk kidneys may help solve organ shortage facing older adultsNovember 14, 2007WINSTON-SALEM, N.C. - New research from Wake Forest University Baptist Medical Center suggests that age alone shouldn't be a barrier to receiving a kidney transplant - and that using donated kidneys that would once have been discarded may help alleviate the burgeoning organ shortage among older adults. "In the recent past, chronological age has been a considered a barrier for both organ donation and transplantation," said Phillip Moore, M.D., lead author. "Our experience suggests that by transplanting organs that are considered higher-risk into carefully selected elderly patients, waiting times can be reduced and survival is similar, compared to standard-organ transplants." The research, which involved 356 kidney transplants over a 59-month period, is reported in the journal Surgery. Because of the aging population, there is an increasing need for kidney transplants among older adults. While the number of patients younger than 50 added to the waiting list for kidney transplants has remained constant during the last decade, the number of patients who are 65 or older has tripled. More than half of the people on the current active list are over age 50. "The crisis in organ supply challenges the transplant community to maximize the use of organs from all consenting donors," said Moore, a surgery resident. In 2002, the United Network for Organ Sharing instituted a new policy to make better use of higher-risk organs that were once considered unsuitable for transplantation. These organs from "expanded criteria" donors (ECD) include kidneys from deceased donors over age 60 years or those over age 50 with health conditions such as high blood pressure, stroke or elevated levels of a protein called creatinine. Levels of creatinine, which is produced by muscle, are used to determine kidney function. "Controversy exists regarding the optimal approach to the elderly donor and recipient," said Moore. "Ethical concerns have been expressed that providing elderly patients who have end-state renal disease with scarce kidneys from deceased donors may not represent a worthwhile investment." Some studies have shown that being older is associated with a higher risk of the transplant failing; other studies have shown that survival of the transplanted organ is similar in all age groups. Moore's study reviewed 356 transplants over almost six years with respect to recipient age. Almost one-third of patients were over age 60 and more half of them (54 percent) received ECD kidneys. There were 26 recipients over age 70 and the oldest recipient was 81 years old. Patient and organ survival rates were similar regardless of patient age - and whether they received an ECD or a standard-criteria donor organ. In addition, the mean waiting time for patients over 60 receiving ECD kidneys was 18 months, compared to 25 months for those receiving standard criteria donor kidneys. With a mean follow-up of 27 months, patient survival was 91 percent among patients older than 60 years and 95 percent among those younger than 60 years. Survival of the transplanted organ was similar for all age groups: 82 percent in patients over age 60, 83 percent in patients between 40 and 59 years old, and 87 percent in patients 19 to 39 years old. Survival rates were also similar between patients receiving ECD kidneys and those receiving standard kidneys. Patient survival rates were 93 percent and 89 percent respectively, and kidney survival rates were 82 percent and 81 percent. In the subgroup of recipients over age 70, patient and graft survival rates were both 100. "By directing ECD kidneys to appropriate elderly patients, waiting times can be reduced and survival is similar compared to standard kidneys in the elderly," said Moore. "At our center, no specific upper age limit is an absolute barrier to kidney transplantation." Kidney transplantation is a preferred treatment for end-stage renal failure, which increases disproportionately with older age. Transplantation is associated with an improved life expectancy and better quality of life and is cost-effective for patients and payers. "Transplantation between older donors and recipients has resulted in a doubling of the annual transplant activity at our center in the past five years," said Moore. Wake Forest University Baptist Medical Center |
|||||||||||||||||||||
| Related Kidney Transplant Current Events and Kidney Transplant News Articles High Blood Pressure Easy to Miss in Children with Kidney Disease Spot blood pressure readings in children with chronic kidney disease often fail to detect hypertension - even during doctor's office visits - increasing a child's risk for serious heart problems, according to research from Johns Hopkins Children's Center and other institutions. A report of the findings appears online in the Journal of American Society of Nephrology. Switching immunosuppressants reduces cancer risk in kidney Switching to a newer type of immunosuppressant drug may reduce the high rate of skin cancer after kidney transplantation, according to research being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA. Kidney transplants generally safe for lupus patients Individuals with a history of lupus who receive a kidney transplant rarely develop the serious inflammatory condition lupus nephritis in their new organ, according to a paper being presented at the American Society of Nephrology's 42nd Annual Meeting and Scientific Exposition in San Diego, CA. Kidneys from deceased donors with acute renal failure expand donor pool Kidneys recovered from deceased donors with acute renal failure (ARF) - once deemed unusable for transplant - appear to work just as well as kidneys transplanted from deceased donors who do not develop kidney problems prior to organ donation. Link between depression, early stages of chronic kidney disease found by researchers One in five patients with chronic kidney disease is depressed, even before beginning long-term dialysis therapy or developing end-stage renal disease, UT Southwestern Medical Center researchers have found. New Discovery Brings Hope to Treatment of Lymphatic Diseases Researchers in the laboratory of Dr. Jayakrishna Ambati at the University of Kentucky have discovered the first naturally occurring molecule that selectively blocks lymphatic vessel growth. Mars and Venus: Short- and long-term success of male to female kidney transplants Female recipients of kidneys from deceased male donors demonstrate an increased risk of allograft failure in the first year after transplant, but show no increased risk after ten years. Post-transplant combo can replace toxic immune-suppressing drugs in monkeys Transplant patients rely on drugs to prevent graft rejection, but at the cost of serious side effects. Johns Hopkins leads first 16-patient, multicenter 'domino donor' kidney transplant Surgical teams at The Johns Hopkins Hospital, Barnes-Jewish Hospital in St. Louis, INTEGRIS Baptist Medical Center in Oklahoma City and Henry Ford Hospital in Detroit successfully completed the first eight-way, multihospital, domino kidney transplant. Microscopic 'beads' could help create 'designer' immune cells that ignore transplanted organs The future of organ transplantation could include microscopic beads that create "designer" immune cells to help patients tolerate their new organ, Medical College of Georgia researchers say. More Kidney Transplant Current Events and Kidney Transplant News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||